phaseollin (isoflavan) has been researched along with Prostatic Neoplasms in 1 studies
*Prostatic Neoplasms: Tumors or cancer of the PROSTATE. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Forster, P; Iranshahi, M; Pham, N; Quinn, RJ; Vu, H; Zencak, D | 1 |
1 other study(ies) available for phaseollin (isoflavan) and Prostatic Neoplasms
Article | Year |
---|---|
Cytotoxic evaluation of alkaloids and isoflavonoids from the Australian tree Erythrina vespertilio.
Topics: Alkaloids; Antineoplastic Agents, Phytogenic; Australia; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Cytotoxins; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Erythrina; Fibroblasts; Flavonoids; Foreskin; Fruit; Humans; Infant, Newborn; Inhibitory Concentration 50; Isoflavones; Male; Plant Bark; Plant Stems; Prostatic Neoplasms; Pterocarpans; Seeds; Structure-Activity Relationship | 2012 |